Keratocyte Density Is Reduced and Related to Corneal Nerve Damage in Diabetic Neuropathy by Kalteniece, Alise et al.
Cornea
Keratocyte Density Is Reduced and Related to Corneal
Nerve Damage in Diabetic Neuropathy
Alise Kalteniece,1,2 Maryam Ferdousi,1,2 Shazli Azmi,1,2 Andrew Marshall,1,2 Handrean Soran,1,2
and Rayaz A. Malik1–3
1Institute of Cardiovascular Sciences, Cardiac Centre, Faculty of Medical and Human Sciences, University of Manchester,
Manchester, United Kingdom
2National Institute for Health Research, Wellcome Trust Clinical Research Facility, Manchester, United Kingdom
3Weill Cornell Medicine-Qatar, Research Division, Qatar Foundation, Education City, Doha, Qatar
Correspondence: Rayaz A. Malik,
Institute of Cardiovascular Sciences,
Cardiac Centre, University of Man-
chester School of Medicine, 46
Grafton Street, Manchester M13 9NT,
UK;
ram2045@qatar-med.cornell.edu.
Submitted: January 17, 2018
Accepted: May 14, 2018
Citation: Kalteniece A, Ferdousi M,
Azmi S, Marshall A, Soran H, Malik RA.
Keratocyte density is reduced and
related to corneal nerve damage in
diabetic neuropathy. Invest Ophthal-
mol Vis Sci. 2018;59:3584–3590.
https://doi.org/10.1167/iovs.18-23889
PURPOSE. The purpose of this study was to assess the relationship between corneal keratocyte
density (KD) and corneal nerve damage in patients with and without diabetic peripheral
neuropathy.
METHODS. Eighty-six patients with type 1 and type 2 diabetes and 21 age-matched control
subjects underwent assessment of the neuropathy disability score, quantitative sensory
testing, electrophysiology, and corneal confocal microscopy and were divided into those
without (DN) (n ¼ 22) and with (DNþ) (n ¼ 64) diabetic neuropathy. Corneal sub-basal
nerve parameters and KD in the anterior, mid, and posterior stroma were quantified.
RESULTS. Anterior, mid, and posterior stromal KD were significantly reduced in DN (P ¼
0.02, P ¼ 0.009, P ¼ 0.01, respectively) and DNþ (all P < 0.0001) subjects compared to
controls. Corneal nerve branch density (CNBD) (P < 0.0001, P < 0.0001) and corneal nerve
fiber length (CNFL) (P ¼ 0.03, P < 0.0001) were significantly reduced in DN and DNþ
subjects, respectively, and corneal nerve fiber density (CNFD) (P < 0.0001) was significantly
reduced only in DNþ subjects compared to controls. Anterior, mid, and posterior stromal KD
correlated significantly with CNFD (P ¼ 0.008, P ¼ 0.005, P ¼ 0.01), CNBD (P ¼ 0.01, P ¼
0.006, P ¼ 0.001), and CNFL (P ¼ 0.04, P ¼ 0.008, P ¼ 0.003), respectively.
CONCLUSIONS. This study demonstrates a reduction in anterior, mid, and posterior KD, which is
associated with corneal sub-basal plexus nerve damage in patients with diabetes.
Keywords: corneal confocal microscopy, diabetic peripheral neuropathy, corneal nerves,
keratocytes
Corneal confocal microscopy (CCM) is a rapid, noninvasiveophthalmic imaging technique that has been utilized to
quantify corneal nerve degeneration and regeneration in a
range of neurodegenerative disorders, particularly diabetic
neuropathy (DN).1,2 CCM has also been utilized to show
varying degrees of abnormality in the epithelium, stroma, and
endothelium of patients with diabetes.3 We have previously
shown that a reduction in epithelial cell density is related to
corneal nerve fiber density (CNFD) in patients with diabetes.4
The stroma comprises approximately 90% of the corneal
volume and contains keratocytes, collagen fibrils, proteogly-
cans, ions, and interstitial substance.5 Keratocytes are a
population of mesenchymal cells originally derived from
neural-crest cells.6 They are comparable to fibroblasts and can
be observed using CCM as hyperreflective spindle or osteo-
blast-shaped cells.7 They play a major role in maintaining
corneal transparency, mechanical stability, and corneal repair6
and are capable of synthesizing collagen, glycosaminoglycans,
and matrix metalloproteases (MMPs).8 Keratocytes form a
network of dendritic processes that encircle stromal nerve
fibers,9 and a recent experimental study has shown that
activated stromal fibroblasts, derived from stromal keratocytes,
induce neurite outgrowth by secreting a range of neurotro-
phins and cytokines.10 A reduction in corneal keratocyte
density (KD) has been implicated in delayed corneal nerve
regeneration after LASIK.11,12 However, previous studies have
reported either a reduction or no change in KD in patients with
diabetes.13–15
The aim of this study was to quantify anterior, mid, and
posterior stromal KD in relation to corneal nerve morphology
in patients with and without DN.
METHODS
Study Subjects
Eighty-six patients with type 1 and type 2 diabetes and 21 age-
matched healthy controls underwent assessment of peripheral
neuropathy, slit lamp examination, and CCM. Patients were
excluded if they had a history of malignancy, another cause of
neuropathy, current or active diabetic foot ulceration, deficien-
cy of B12 or folate, chronic renal or liver failure, connective
tissue or systemic disease, corneal trauma, systemic disease that
involves the cornea, and cystic corneal disorders. Patients with
a history of contact lens wear were excluded from the study.
Before participation, informed consent was obtained from each
participant. The research was approved by North Manchester
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Research Ethics Committee and adhered to the tenets of
Declaration of Helsinki.
Clinical and Peripheral Neuropathy Assessment
All participants underwent assessment of body mass index
(BMI), glycated hemoglobin (HbA1c), and total cholesterol.
Neurologic deficits were assessed using the neuropathy
disability score (NDS), which includes an assessment of
vibration perception, pinprick, temperature sensation, and
presence or absence of ankle reflexes.16 Vibration perception
threshold (VPT) was assessed using a neurothesiometer
(Scientific Laboratory Supplies, Wilfrod, Nottingham, UK).
Cold (CTs) and warm (WTs) thresholds were assessed on the
dorsolateral aspect of the left foot using a neurosensory
analyzer (TSA-II NeuroSensory Analyzer; Medoc, Ltd., Ramat-
Yishai, Israel). A consultant neurophysiologist assessed sural
sensory nerve amplitude (SSNA), sural sensory nerve conduc-
tion velocity (SSNCV), peroneal motor nerve amplitude
(PMNA), and peroneal motor nerve conduction velocity
(PMNCV) using a nerve conduction testing machine (Keypoint
System; Dantec Dynamics Ltd., Bristol, North Somerset, UK),
equipped with a temperature regulator (DISA; Dantec, Den-
mark) to keep the limb temperature constantly at 328 to 358C.
Ophthalmic Examination
Participants underwent slit lamp examination, noncontact
corneal esthesiometry, and CCM. CCM was performed using
laser scanning corneal confocal microscopy HRTIII with a
corneal module (HRTIII with Rostock Corneal module;
Heidelberg Engineering, Heidelberg, Germany) for both eyes
following our previously established protocol.17 The illumina-
tion source is a 670-nm diode laser, a class 1 laser system. The
size of the laser beam spot was 1 lm in diameter, and the
instrument field of view was 400 3 400 lm with a 633
objective lens. Two-dimensional digital images were obtained
with a resolution of 10 lm/pixel and a size of 3843384 pixels.
A charge-coupled device camera attached to the microscope
provided live imaging of the cornea and showed the exact
location for the examination. Corneal sensation threshold was
assessed using a noncontact corneal esthesiometer (NCCA)
(Glasgow Caledonian University, Glasgow, Scotland, UK).
Corneal Nerve Assessment. Six images (three images per
eye) from the sub-basal nerve plexus were selected for quality,
depth, contrast, and location in the cornea according to our
previously published protocol.18 Corneal nerve fiber density
(CNFD) (total number of main nerves per square millimeter;
no./mm2), corneal nerve branch density (CNBD) (number of
nerve branches per square millimeter; no./mm2), and corneal
nerve fiber length (CNFL) (total length of main nerves and
nerve branches per square millimeter; mm/mm2) were
manually analyzed using image analysis software (CCMetrics;
M.A. Dabbah, Imaging Science, The University of Manchester,
Manchester, UK).
Keratocyte Density. The anterior stroma was defined as
the very first high-quality image below Bowman’s layer; the
posterior stroma was defined as the very first high-quality
image just before the endothelium; and the midstroma was an
image between the anterior and posterior stromal images.
Keratocytes were defined as hyperreflective spindle or
osteoblast-shaped nuclei against a dark background7 and were
manually counted using CCMetrics (Imaging Science, The
University of Manchester, Manchester, UK). KD (cells/mm2)
was obtained by counting the number of cells per square
millimeter.
Inter- and Intraobserver Variability of KD. To measure
the intraobserver variability, KD was measured in a subset of
images from 15 patients on two separate occasions by observer
1 within a 1-month interval. To assess the interobserver
agreement, two observers (observer 1 and 2) analyzed images
TABLE 1. Clinical Demographics, Neuropathy Assessment, and CCM in Patients (DN and DNþ) Compared to Controls
Controls, n ¼ 21 DN, n ¼ 22 DNþ, n ¼ 64
Age, y 57.57 6 2.4 61.66 6 1.95 63.85 6 1.31*
Sex, female/male 12/9 8/14 19/45
Diabetes duration, y N/A 10.47 6 1.69§ 23.24 6 2.37
T1DM/T2DM N/A 5/17 24/40
BP systolic, mm Hg 131.19 6 3.84 132.35 6 4.1 135.52 6 2.25
Cholesterol, mM 5.19 6 0.18 4.61 6 0.2*§ 3.91 6 0.11‡
BMI, kg/m2 27.63 6 1.01 28.12 6 1.19 30.52 6 1.07
HbA1c, % 5.70 6 0.05 6.43 6 0.22† 7.26 6 0.2‡
NCCA, mbars 0.63 6 0.12 0.56 6 0.12† 1.06 6 0.18
CNFD, no./mm2 29.09 6 1.19 26.54 6 1.07§ 21.27 6 0.95‡
CNBD, no./mm2 96.85 6 4.42 63.6 6 7.15‡† 47.74 6 3.43‡
CNFL, mm/mm2 28.99 6 0.87 24.7 6 1.3*§ 19.65 6 0.89‡
AKD, no./mm2 650.14 6 29 540.93 6 26.53*§ 425.19 6 21.2‡
MKD, no./mm2 405.5 6 9.12 363.27 6 12.17‡† 336.56 6 6.77‡
PKD, no./mm2 391.21 6 10.45 351.9 6 13.29*† 326.77 6 5.98‡
PMNCV, m/s 46.77 6 0.81 43.56 6 0.74§ 38.9 6 0.87‡
SSNCV, m/s 48.48 6 1.05 45.4 6 1.02§ 40.47 6 0.82*
PMNA, mV 4.55 6 0.3 4.7 6 0.51§ 2.78 6 0.24‡
SSNA, lV 18.52 6 2.0 9.56 6 1.23‡ 6.45 6 0.74‡
CT, 8C 27.31 6 0.55 28.05 6 0.32§ 21.99 6 1.19‡
WT, 8C 38.24 6 0.8 39.5 6 0.61§ 43.51 6 0.59‡
VPT, V 7.67 6 1.27 11.53 6 1.14† 25.09 6 1.55*
* P < 0.05 compared to controls.
† P < 0.05 compared to DNþ.
‡ P < 0.01 compared to controls.
§ P < 0.01 compared to DNþ.
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FIGURE 1. CCM images in healthy control (A1–A4), patient without DN (B1–B4), and patient with DN (C1–C4) of the corneal sub-basal nerve
plexus (A1–C1), anterior stroma (A2–C2), midstroma (A3–C3), and posterior stroma (A4–C4).
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in a subset of images from 15 patients following the same
protocol.
Statistical Analysis
Analysis was carried out using statistical software (SPSS,
Version 22.0 for Macintosh; IBM Corporation, New York, NY,
USA). All data were presented as mean 6 SE. Descriptive and
frequency statistics were used to describe the data. Indepen-
dent sample t-test (Mann-Whitney U test for nonparametric)
and 1-way ANOVA (post hoc least significant difference) were
used to assess the estimates between groups. For all values, P
< 0.05 was considered as significant. To assess the inter- and
intraobserver agreement, Bland-Altman plots and the intraclass
correlation coefficient (ICC) were measured. Pearson correla-
tion (Spearman for nonparametric) was calculated to assess the
association between corneal nerve parameters, demographic
data, and KD.
RESULTS
Clinical and Peripheral Neuropathy Assessment
BMI and systolic blood pressure were comparable, total
cholesterol (P < 0.0001) was lower, and HbA1c (P <
0.0001) was significantly higher in patients with diabetes
compared to control subjects. Total cholesterol (P ¼ 0.002)
was higher and HbA1c (P ¼ 0.01) was significantly lower in
DN compared to DNþ patients, respectively. SSNCV (P <
0.0001), SSNA (P < 0.0001), PMNCV (P < 0.0001), PMNA (P¼
0.002), and CT (P¼0.001) were significantly lower, and WT (P
< 0.0001) and VPT (P < 0.0001) were significantly higher in
patients with diabetes compared to control subjects. PMNCV
(P¼0.001), PMNA (P < 0.0001), SSNCV (P¼0.001), and CT (P
¼ 0.001) were significantly lower, and WT (P < 0.0001), VPT
(P < 0.0001), and corneal sensation threshold (P¼ 0.03) were
significantly higher in DNþ compared to DN patients (Table
1).
Corneal Confocal Microscopy
Corneal Nerves. CNFD (P < 0.0001), CNBD (P < 0.0001),
and CNFL (P < 0.0001) were significantly lower in patients
with diabetes compared to controls. CNBD (P < 0.0001) and
CNFL (P ¼ 0.03) were significantly lower in DN patients
compared to controls. CNFD (P ¼ 0.002), CNBD (P ¼ 0.02),
FIGURE 2. Anterior, mid, and posterior stromal KD in healthy controls,
diabetic patients without and with DN (DN and DNþ, respectively); P
values under the dashed line compare KD in controls compared to
DNþ, P values under the dotted line compare KD in controls compared
to DN; P values under the solid line compare KD in DN compared
to DNþ.
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and CNFL (P ¼ 0.002) were significantly lower in DNþ
compared to DN patients (Table 1; Fig. 1).
Corneal Keratocytes. Anterior (P < 0.0001), mid (P <
0.0001), and posterior (P < 0.0001) stromal KD were
significantly lower in patients with diabetes compared to
controls. Anterior, mid, and posterior stromal KD were
reduced in DN (P ¼ 0.02, P ¼ 0.009, P ¼ 0.01, respectively)
and DNþpatients (all P < 0.0001) compared to controls (Table
1; Figs. 1, 2). In addition, the anterior (P ¼ 0.003), mid (P ¼
0.04), and posterior (P ¼ 0.05) stromal KD were significantly
lower in DNþ compared to DN groups (Table 1; Figs. 1, 2).
Anterior (434.75 6 38.61 vs. 465.84 6 19.82, P ¼ 0.4), mid
(333.09 6 12.89 vs. 348.27 6 6.76, P¼ 0.3), and posterior KD
(336.7 6 10.71 vs. 331.22 6 7.03, P ¼ 0.6) did not differ
significantly between patients with type 1 and type 2 diabetes.
Correlations With KD
Anterior, mid, and posterior stromal KD correlated significantly
with CNFD (r¼0.26, P¼ 0.008; r¼0.27, P¼ 0.005; r¼0.24, P
¼0.01), CNBD (r¼ 0.23, P¼0.01; r¼0.27, P¼0.006; r¼0.32,
P¼ 0.001), and CNFL (r¼ 0.20, P¼ 0.04; r¼ 0.26, P¼ 0.008; r
¼ 0.29, P ¼ 0.003), respectively. Anterior, mid, and posterior
stromal KD also correlated negatively with age (r ¼0.5, P <
0.0001; r ¼ 0.32, P ¼ 0.001; r ¼ 0.37, P < 0.0001);
midstromal KD correlated negatively with the duration of
diabetes (r ¼0.23, P ¼ 0.04); and anterior (r ¼0.42, P <
0.0001) and posterior (r ¼ 0.24, P ¼ 0.02) stromal KD
correlated significantly with HbA1c (Table 2).
Intra- and Interobserver Agreement
Excellent intraobserver (Figs. 3A–C) and good interobserver
(Figs. 3D–F) agreement was found for anterior (ICC ¼ 0.91
versus ICC ¼ 0.88), mid (ICC ¼ 0.95 versus ICC ¼ 0.81), and
posterior KD (ICC ¼ 0.91 versus ICC ¼ 0.77), respectively.
There was a significant intraobserver correlation for anterior
KD (r¼ 0.91, P < 0.0001), mid KD (r¼ 0.9, P < 0.0001), and
posterior KD (r ¼ 0.85, P < 0.0001). There was a significant
interobserver correlation for anterior KD (r ¼ 0.83, P <
FIGURE 3. Bland-Altman plots for intraobserver agreement (A–C) and interobserver agreement (D–F) for anterior, mid, and posterior.
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0.0001), mid KD (r¼ 0.81, P < 0.0001), and posterior KD (r¼
0.63, P ¼ 0.01).
DISCUSSION
This study demonstrates a reduction in anterior, mid, and
posterior stromal KD in patients with and without DN and
excellent intraobserver and interobserver agreements for our
method of quantification. Previous studies have shown varying
results compared to our study as Frueh et al.14 found no
change in KD in patients with type 1 and type 2 diabetes
compared to controls, despite a reduction in stromal nerves.
Quadrado et al.15 also found no significant difference in stromal
KD in patients with diabetes compared to control subjects, and
a previous study in young patients with type 1 diabetes even
demonstrated an increase in posterior KD.19 However, Bitirgen
et al.13 showed a significant reduction in anterior KD in
patients with type 2 diabetes and retinopathy. These differ-
ences may be attributed to differing populations studied in
relation to age, diabetes type and duration, and examination of
different stromal layers. Another concern may be that CCM
images may not allow adequate identification of keratocytes;
however Patel et al.20 have validated this technique by
comparing KD in CCM images with histologic examination.
Contact lens use has also been shown to reduce keratocyte cell
density21 and stromal thinning22,23; therefore, patients wearing
contact lenses were excluded from this study.
Diabetes is associated with widespread pathology of the
cornea, including a reduction in epithelial, keratocyte, nerve,
and endothelial cell densities24,25 attributed to increased
advanced glycation.26 Indeed, in the present study we have
shown a significant correlation between KD and both duration
of diabetes and HbA1c. We have also shown a significant
association between stromal KD and age, which is in
agreement with Patel et al.,20 who also reported a significant
correlation between KD and age.
Very few studies have evaluated the relationship between
stromal KD and corneal sub-basal nerve plexus morphology. In
a recent study, while both intermediate and basal epithelial cell
density correlated with CNFD, there was no reduction in
anterior KD or correlation with CNFD.4 We have shown a
reduction in the anterior, mid, and posterior KDs even in
patients without DN and a further reduction in patients with
DN. The greatest loss was in the anterior (29.8%) compared to
the mid (15.1%) and posterior (14.8%) KDs, which may be
relevant given that this layer is immediately below the sub-
basal nerve plexus. Despite the majority of patients in this
cohort having mild DN, we still showed a moderate but
significant correlation between KD and corneal nerve mor-
phology. It would be of interest to include patients with severe
DN as this may further strengthen the association between KD
and corneal nerve loss.
A recent experimental study by Yam et al.10 showed that
activated stromal fibroblasts derived from corneal stromal
keratocytes induced neurite outgrowth by releasing a range of
neurotrophic and proinflammatory factors, including IL-8, IL-
15, eotaxin, monocyte chemoattractant protein-1, and the
protein RANTES. Several previous studies have shown corneal
nerve fiber repair after continuous subcutaneous insulin
infusion,27 simultaneous pancreas and kidney transplanta-
tion,28 and use of the nonerthropoietic peptide Cibinetide.29,30
However, these studies did not assess a change in KD in
relation to nerve repair.
In conclusion, we demonstrate a reduction in anterior, mid
and posterior stromal KD that relates to age, duration of
diabetes, and glycemic control. This occurs early in patients
without DN with a further reduction in those with DN. The
modest correlations between KD and corneal nerve morphol-
ogy suggest a small but significant relationship between
keratocytes and corneal nerve integrity.
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